BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8650812)

  • 1. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
    Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of amiodarone pulmonary toxicity.
    Kennedy JI
    Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amiodarone and the lung].
    Mendonça C; Pereira A; Longo S; Lousada N; Loureiro A; Correia JF
    Rev Port Cardiol; 1996 Oct; 15(10):745-51. PubMed ID: 9115769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone pulmonary toxicity.
    Camus P; Martin WJ; Rosenow EC
    Clin Chest Med; 2004 Mar; 25(1):65-75. PubMed ID: 15062598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
    Nalos PC; Kass RM; Gang ES; Fishbein MC; Mandel WJ; Peter T
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):904-12. PubMed ID: 3573800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of amiodarone therapy: efficacy and side effects.
    Hilleman D; Miller MA; Parker R; Doering P; Pieper JA
    Pharmacotherapy; 1998; 18(6 Pt 2):138S-145S. PubMed ID: 9855346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings.
    Kimura T; Kuramochi S; Katayama T; Yoshikawa T; Yamada T; Ueda Y; Okada Y
    Pathol Int; 2008 Oct; 58(10):657-63. PubMed ID: 18801087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
    Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
    Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amiodarone pulmonary toxicity].
    Mazzei L; Sposato B; Propati A; Gidaro M; Sciotto V; De Angelis G
    Recenti Prog Med; 1999 Dec; 90(12):658-62. PubMed ID: 10676107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal pulmonary toxicity after a single dose of cyclophosphamide.
    Gupta S; Mahipal A
    Pharmacotherapy; 2007 Apr; 27(4):616-8. PubMed ID: 17381391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced pulmonary toxicity: potentially fatal, recognize early during life!
    Dharmarajan TS; Shah AB; Dharmarajan L
    J Am Geriatr Soc; 2008 Jul; 56(7):1363-5. PubMed ID: 18774973
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance.
    Sunderji R; Kanji Z; Gin K
    Can J Cardiol; 2000 Nov; 16(11):1435-40. PubMed ID: 11109040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of amiodarone pulmonary toxicity.
    Martin WJ
    Clin Chest Med; 1990 Mar; 11(1):131-8. PubMed ID: 2182274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
    Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
    Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.
    Mankikian J; Favelle O; Guillon A; Guilleminault L; Cormier B; Jonville-Béra AP; Perrotin D; Diot P; Marchand-Adam S
    Respir Med; 2014 Apr; 108(4):638-46. PubMed ID: 24565600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.
    Jarand J; Lee A; Leigh R
    CMAJ; 2007 May; 176(10):1411-3. PubMed ID: 17485692
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.
    Devine PL; Siebert WJ; Morton SL; Scells B; Quin RJ; Heddle WF; Zimmerman PV; Donohoe PJ
    Dis Markers; 1998 Nov; 14(3):169-75. PubMed ID: 10427477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.